CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 132 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$568,000
-17.0%
167,000
-8.1%
0.00%0.0%
Q2 2018$684,000
-14.9%
181,800
-7.5%
0.00%0.0%
Q1 2018$804,000
-12.0%
196,6000.0%0.00%0.0%
Q4 2017$914,000
-34.5%
196,6000.0%0.00%
-50.0%
Q3 2017$1,396,000
-1.8%
196,6000.0%0.00%0.0%
Q2 2017$1,421,000
+17.3%
196,6000.0%0.00%0.0%
Q1 2017$1,211,000
+0.7%
196,600
-4.1%
0.00%0.0%
Q4 2016$1,202,000
+10.4%
205,1000.0%0.00%0.0%
Q3 2016$1,089,000
-24.9%
205,100
-6.4%
0.00%0.0%
Q2 2016$1,451,000
+37.4%
219,200
-3.1%
0.00%0.0%
Q1 2016$1,056,000
-12.8%
226,100
-5.7%
0.00%0.0%
Q4 2015$1,211,000
+43.5%
239,8000.0%0.00%
+100.0%
Q3 2015$844,000
-64.7%
239,8000.0%0.00%
-75.0%
Q2 2015$2,393,000
-23.6%
239,8000.0%0.00%0.0%
Q1 2015$3,134,0000.0%239,8000.0%0.00%0.0%
Q4 2014$3,134,000
+12.5%
239,800
+18.4%
0.00%0.0%
Q3 2014$2,786,000
-10.6%
202,6000.0%0.00%0.0%
Q2 2014$3,116,000
-9.4%
202,600
-8.9%
0.00%
-20.0%
Q1 2014$3,441,000
+29.6%
222,350
+9.7%
0.01%
+25.0%
Q4 2013$2,656,000
+27.5%
202,600
-1.7%
0.00%0.0%
Q3 2013$2,083,000
+60.1%
206,200
+18.4%
0.00%
+33.3%
Q2 2013$1,301,000174,2000.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
VHCP Management, LLC 700,273$10,770,0005.76%
HARVEY CAPITAL MANAGEMENT INC 932,400$14,340,0005.13%
Camber Capital Management LP 3,000,000$46,140,0003.02%
Baupost Group 10,539,986$162,105,0002.64%
SECTORAL ASSET MANAGEMENT INC 3,741,656$57,547,0002.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,884,409$59,742,0002.40%
Knoll Capital Management, LLC 200,000$3,076,0001.37%
DAFNA Capital Management LLC 92,400$1,421,0001.35%
NORTHPOINTE CAPITAL LLC 892,011$13,719,0001.32%
Rhenman & Partners Asset Management AB 240,000$3,691,0001.10%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders